"I have always considered certification an honor and am proud to have achieved that. It is nice to be recognized as knowledgeable about transplants. This does aid in providing excellent care to our transplant patients." Thank you so much Carolyn for this testimonial! Get to know more about ABTC and read our other testimonials here -> https://bit.ly/3D5HrH5!
American Board for Transplant Certification’s Post
More Relevant Posts
-
Do you know how to treat refractory or resistant #CMV in transplant patients? Learn more from Drs. Humar and Papanicolaou and a patient in no-cost CME activity below! #MedEd #CME #Transplant https://ow.ly/Jsxw50QGt3R
-
-
Everyday #Barostim is available in more healthcare systems and hospitals across the country. This is great news for #heartfailure patients. Having more options available to help them get relief of their symptoms and a better quality of life. #outsmarttheheart #cardiology #cardiothoracicsurgery #vascularsurgery #electrophysiology #innovationinhealthcare #healthcareinnovation #medtech #meddevice #medicaldevices
We're honored to partner with Drs. Marat Fudim, Chandler Long, Adam DeVore and Dennis Abraham and the team at Duke University Hospital on their first #Barostim implant. Thanks for providing a novel therapy option for your #heartfailure patients.
-
-
Do you know how to treat refractory or resistant #CMV in transplant patients? Learn more from Drs. Humar and Papanicolaou and a patient in no-cost CME activity below! #MedEd #CME #Transplant https://ow.ly/MIeP50QGsLZ
-
-
These Clinical Lab Products case studies detail how SeptiCyte® RAPID differentiated between #sepsis and SIRS in two #EmergencyDepartment patients. SeptiCyte® RAPID improved turnaround times and diagnostic accuracy, buying clinicians critical time to administer life-saving treatments. Read the full article here: https://lnkd.in/euVQQhfF
-
-
SEE THE POSITIVES OF KNOWING THE NEGATIVE Silent rejection is common, happening in 25% of transplant patients. But knowing earlier = treating earlier. Visit https://lnkd.in/gXbwQER8 to learn more! #SilentRejection #KidneyTransplantRejection #GetAheadOfRejection #TruGraf #TGI #TransplantGenomics
-
SEE THE POSITIVES OF KNOWING THE NEGATIVE Silent rejection is common, happening in 25% of transplant patients. But knowing earlier = treating earlier. Visit https://lnkd.in/gXbwQER8 to learn more! #SilentRejection #KidneyTransplantRejection #GetAheadOfRejection #TruGraf #TGI #TransplantGenomics
-
-
SEE THE POSITIVES OF KNOWING THE NEGATIVE Silent rejection is common, happening in 25% of transplant patients. But knowing earlier = treating earlier. Visit https://lnkd.in/gXbwQER8 to learn more! #SilentRejection #KidneyTransplantRejection #GetAheadOfRejection #TruGraf #TGI #TransplantGenomics
-
-
In this edition of In The Network, we explore why creating an empowering patient experience is important and how practices can support patients. Read the article > https://hubs.li/Q02Zk6lw0 #InTheNetwork #CancerCare #WeAreAON #PatientJourney
-
Do you know how to treat refractory or resistant #CMV in transplant patients? Learn more from Drs. Humar and Papanicolaou and a patient in no-cost CME activity below! #MedEd #CME #Transplant https://ow.ly/86Ey50QGt8o
-
-
Business Development Manager - Immunexpress / SeptiCyte RAPID - 1st FDA cleared host-response, Gene Expression, for Sepsis, that aids clinicians to make time sensitive decisions to reduce mortality!
🥸 News you can use. In this article, the FDA cleared SeptiCyte RAPID - host-response, gene-expression test, shows utility of sepsis diagnosis in two case studies illustrate how this novel life-saving sepsis test improves turnaround times and diagnostic accuracy, buying clinicians critical time to administer time sensitive treatments and reduce mortality 💜! DM me to schedule a meeting. #sepsis #infectionprevention #ICU #ED #EM #Moleculardiagnostics #patientsafety
These Clinical Lab Products case studies detail how SeptiCyte® RAPID differentiated between #sepsis and SIRS in two #EmergencyDepartment patients. SeptiCyte® RAPID improved turnaround times and diagnostic accuracy, buying clinicians critical time to administer life-saving treatments. Read the full article here: https://lnkd.in/euVQQhfF
-
